HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of DNMTs and H3K9ac in Ameloblastoma and Ameloblastic Carcinoma.

Abstract
Objectives: DNA methyltransferases (DNMTs) and the histone modification H3K9ac are epigenetic markers. This study aimed to describe the immunohistochemical expression of DNMT1, DNMT3A, DNMT3B, and H3K9ac in the dental follicle (DF), ameloblastoma (AME), and ameloblastic carcinoma (AC), correlating these expressions with the recurrence and aggressive behavior in ameloblastoma. Study Design: Immunohistochemical reactions were performed in 10 human DFs, 38 ameloblastomas, and 6 AC samples. Another 59 ameloblastomas assembled in a tissue microarray were used to compare the immunoexpression with the clinical, radiographic, and histopathological characteristics and the presence of BRAFv600e mutation. Each slide was digitized as a high-resolution image and quantified by Aperio ScanScope Nuclear V9 software. All statistical analyzes were performed using GraphPad Prism statistical software. Results: DNMT3B expression was higher in ameloblastomas than in the DFs, while the AC overexpressed all proteins. The ameloblastomas with BRAFv600e mutation, vestibular/lingual, or vestibular/palatine bone cortical disruption and maxilla involvement showed DNMT1 overexpression, while recurrent cases had high DNMT3B levels. Conclusions: DNA methylation and histone modification might play a role in the development, clinical aggressiveness, and recurrence rates of ameloblastoma, such as the progression to AC. Further investigation about gene methylations in ameloblastomas is needed to better understand its relationship with aggressiveness and recurrence.
AuthorsGleyson Kleber do Amaral-Silva, Thayná Melo de Lima Morais, Vivian Petersen Wagner, Manoela Domingues Martins, Eduardo Rodrigues Fregnani, Fernando Augusto Soares, André Caroli Rocha, Helder Rabelo Pontes, Alan Roger Santos-Silva, Pablo Agustin Vargas
JournalFrontiers in oral health (Front Oral Health) Vol. 2 Pg. 751162 ( 2021) ISSN: 2673-4842 [Electronic] Switzerland
PMID35048062 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Amaral-Silva, Morais, Wagner, Martins, Fregnani, Soares, Rocha, Pontes, Santos-Silva and Vargas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: